Rituximab Treatment and Long-term Outcome of Patients With Autoimmune Encephalitis: Real-world Evidence From the GENERATE Registry.

Franziska S ThalerLuise ZimmermannStefan KammermeierChristine StrippelMarius RingelsteinAndrea KraftKurt-Wolfram SühsJonathan WickelChristian GeisRobert MarkewitzChristian UrbanekClaudia SommerKathrin DopplerLoana PennerJan LewerenzRosa RößlingCarsten FinkeHarald Prüss Nico MelzerKlaus-Peter WandingerFrank LeypoldtTania Kümpfelnull null

Published in: Neurology(R) neuroimmunology & neuroinflammation (2021)

This study provides Class IV evidence that rituximab is an effective treatment for some types of AE.

Keyphrases